梅州微管可视人流注意事项(梅州微创人流手术时间) (今日更新中)

SUVA, Oct. 3 (Xinhua) -- It is Pinktober again and Fiji like the rest of the world will be raising awareness of breast cancer too, Fiji Cancer Society Chairperson and breast cancer awareness month President Nirmala Nambiar has said."Join the fight against breast cancer through early detection and awareness." This is the message the Fiji Cancer Society is sending out this October, which is breast cancer awareness month, worldwide.Fiji Cancer Society Chairperson and breast cancer awareness month President Nirmala Nambiar said, "Fiji continues to have a high incidence of breast cancer deaths with large number of tumors presented to health professionals at a late stage due to the stigma of having the disease."In the first quarter of 2011, there were 46 new breast cancer cases recorded, whilst there were 33 new cases in the same period last year."The figures could be scary but one must understand that as the awareness increases in our communities the number of cases recorded increases," she warned.Men and women should be aware that age, obesity and family history are all factors that contribute to the risk of developing the disease.This October the Fiji Cancer Society has planned a number of events all targeted to raise awareness since the lack of information and education is dangerous.Nambiar said through partnership with the Ministry of Health, Oxfam Clinic in Suva and the Fiji Nurses Association, supported by the sponsorship of Colgate Palmolive, the focus this year is on reaching out to the rural community and making a difference to the lives of the poor and unprivileged."We have free checkups planned for the month at the major villages from Vunidawa, Korovou and Valelevu to Lami at the other end and hope that we will be able to support the women in this area who may not be able to have a check- up otherwise.According to the official, the society's western branch continues to arrange free check- ups with the support of the Patan Clinic.The awareness and free checkups have also been arranged for corporate organizations at their request and if we are not able to provide all this during October we will continue to schedule them for the following month.The Society's thanks go to Suva Private Hospital for offering half price mammograms for the month of October, Nambiar said, adding a common issue with Fiji women, according to doctors at the hospital, was the return rate."Once they hear the news that they have cancer, many women don' t return because of the fear of what's next. Hence the Society is working with the hospitals and helping counsel patients to get them back for treatment rather than fight the losing battle, since 70 percent of cancer cases can be saved through early detection and treatment," she said.The Fiji Cancer Society strongly believes that the success of the awareness program this month will set the platform for the society's ongoing initiative to drive and raise the community's understanding, get them involved and make them take care of each other. 

BEIJING, Dec. 7 (Xinhua) -- The Chinese government on Wednesday released a white paper on its foreign trade, highlighting the country's achievements in boosting foreign trade and contribution to the world economy.The white paper, titled China's Foreign Trade, was released by the Information Office of the State Council.The white paper introduces China's historic progress, international contribution and policies in foreign trade.

WASHINGTON, Dec. 7 (Xinhua) -- The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.Their report, published on-line Wednesday in Gynecologic Oncology, suggests that this combination, ixabepilone and sunitinib, might offer a much needed treatment option for women with advanced ovarian cancer.Neither drug is approved for use in ovarian cancer. Ixabepilone is a chemotherapy drug that, like other taxane drugs, targets the microtubules and stops dividing cells from forming a spindle. It has been approved for use in metastatic breast cancer. Sunitinib, approved for use in kidney cancer, belongs to a class of tyrosine kinase inhibitors that stops growth signals from reaching inside cancer cells.When caught at late stages, ovarian cancer is often fatal because it progressively stops responding to the chemotherapy drugs used to treat it."Women die from ovarian cancer because their tumors become resistant to chemotherapy, so a drug that might be able to reduce that resistance -- which may be what this combination of agents is doing -- would be a boon to treatment of this difficult cancer," says study coauthor Gerardo Colon-Otero.The finding also highlights the importance of the role of a molecule, RhoB, that the researchers say is activated by the drug duo. It might be a potential biomarker that may help identify patients who might benefit from such combination therapy, the researchers say.

WASHINGTON, Dec. 21 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Wednesday approved Isentress for the treatment of HIV-1 infection for children and adolescents.The drug is part of a class of medications called HIV integrase strand transfer inhibitors that works by slowing the spread of HIV in the body. It was first approved for use in adult patients in October 2007, under FDA's accelerated approval program."Many young children and adolescents are living with HIV and this approval provides an important additional option for their treatment," said Edward Cox, director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research.Isentress is a pill that can be taken twice daily, with or without food. The pill is also available in a chewable form. As the two tablet formulations are not interchangeable, the chewable form is only approved for use in children ages 2 to 11.A single, multi-center clinical trial of 96 children and adolescents aged 2-18 years with HIV-1 infection evaluated the safety and effectiveness of Isentress. These patients previously received treatment for HIV-1 infection. After 24 weeks of treatment with Isentress, 53 percent of these patients had an undetectable amount of HIV in their blood.According to the FDA, the most commonly reported severe, treatment-related side effects in patients taking Isentress include trouble sleeping and headache. The frequency of these side effects is similar for children and adults. One pediatric patient reported severe treatment-related insomnia, while another pediatric patient experienced a drug-related skin rash.

KATHMANDU, Oct. 30 (Xinhua) -- "One of the major problems of death due to breast cancer in Nepal is poverty and untimely diagnosis," said Dr. Abish Adhikari Oncologist at the Bir Hospital in Nepali capital Kathmandu in an exclusive interview with Xinhua on Sunday.Adhikari said that the other reason why breast cancer leads to death of women is "women are not decision makers in their houses"."Many people who come here do not want to treat their wives or daughters because of the expenses as they are poor and it is really expensive here to treat cancer," Adhikari said.According to the Nepal Cancer Relief Society, of all cancer cases among the Nepali women and teenage girls as well, 60 percent is of breast cancer.Unverified rough data of the breast cancer patients in Nepal are above 50,000.Adhikari added that women are shy to talk about the problems of breast. They do not go to hospitals for the check up until they are bedridden and at the time they reach hospital they are mostly in the advanced stage.The major causes behind the breast cancer in Nepal are heredity, late pregnancy, consumption of alcohol and smoking. However, unawareness about it remains another major problem that leadind to death of many women in Nepal.Moreover, the rural women in Nepal are unaware about breast cancer, and if they are having some problem, they tend to hide it.Talking to Xinhua, Sajani Manandhar, General Secretary of Richa Bajimaya Memorial Foundation, a cancer awareness raising group said that the major cause of the preventable cancer in Nepal is unawareness.Also a nurse by profession, she said that no one bothers about mammography or regular checkup but are diagnosed at the very late stage.There are less than five hospitals that provide mammography service in the country.Roshani Chitrakar, 48 who is in advanced stage of cancer said that she did not told anyone while she found something unusual in her breast because it was not painful."I took it normally, but when I thought it might be a cancer and told my family and I was already in the advanced stage," she said.Her daughter, Roji Manandhar, said that the doctor has already told that she will not be living long. She is having difficulty even to eat currently.Another cancer patient, 67 years old farmer, Nakkali Nahakhusi said that she told her husband when she found her breast unusual. Her husband, former armyman, immediately took her to the hospital when she told about the problem.Now, she is already cured, and said with smilingly that the god of death did not want to take me away.She said that awareness should be raised because cancer is curable at the early stage.

来源：资阳报